Are the Cardiorenal Benefits of SGLT2 Inhibitors Due to Inhibition of the Sympathetic Nervous System?
Verma, SubodhVolume:
5
Journal:
JACC: Basic to Translational Science
DOI:
10.1016/j.jacbts.2020.01.011
Date:
February, 2020
File:
PDF, 334 KB
2020